Delinquent IBC Policy
The IBC no longer requires human pathogen screening for human cell lines going into
animals. However, the IBC will continue to request information for how the cell
lines are being used/administered in animals, documentation for where the administration
will occur, and how the area will be disinfected after work is completed or in the
event of a spill. All human materials, including cell lines and strains, will
continue to be manipulated according to Biosafety Level 2 (BSL2) practices.
Standard Operating Procedures (SOPs) should accompany all IBC registries. SOPs should
not only address standard biosafety level criteria, but should also specifically
identify hazards as outlined in the IBC registry.
Laboratory Biological Safety Manual and SOP Guidance Document
NCI-F Biological Research Material Handling & Use Policy (Pol. #706)